Abdul Nurudeen, DPM
Foot & Ankle Surgery · Houston, TXNPI 1487016655
Payments from drug & device makers
What this record shows
This record is dominated by other: $386,400 of the $404,249 with a category attached, or 95.6%. Convatec Inc. accounts for 95.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $388,073 and has fallen 99.5% since, to $1,814 in 2025. Among foot & ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $1491.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$386K
- Stryker$8K
- Elite Orthopedics, LLC$3K
- ALON Medical Technology$2K
- Orthofix Medical, Inc.$2K
- Organogenesis Inc.$1K
- plus $1K from 10 others
What the payments were for
- Travel & lodging$3,8151%
- Food & beverage$7,9212%
- Education$5,0281%
- Gifts$1,0850%
- Other$386,40096%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 22 | $386,400 |
| Stryker(2 entities) | 139 | $7,920 |
| Elite Orthopedics, LLC | 1 | $3,157 |
| ALON Medical Technology | 5 | $2,343 |
| Orthofix Medical, Inc. | 29 | $1,660 |
| Organogenesis Inc. | 34 | $1,325 |
| Arthrex | 8 | $567 |
| Smith+Nephew | 20 | $409 |
| Treace Medical Concepts, Inc. | 6 | $172 |
| Integra Lifesciences Corporation | 1 | $139 |
| Alafair Biosciences, Inc. | 1 | $57 |
| GRT US Holding, Inc. | 1 | $30 |
| Sanara Medtech Inc. | 1 | $24 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $19 |
| Bioventus LLC | 1 | $15 |
| Medinc Of Texas | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$386,400
- TL-HEX$1,150
- INFINITY$1,129
- HOFFMANN$989
- TrueLok Ring Fixation System$936
- AUGMENT INJECTABLE$853
- SALVATION$760
- INBONE$493
- PuraPly$431
- GALAXY Fixation$425
- INTEGRA$418
- ANCHORAGE$296
- PURAPLY WOUND MATRIX$196
- ORTHOLOC 3DI$174
- FIXOS$171
- ORTHOLOC 2 LAPIFUSE$170
- EX-FIX$163
- INFINITY ADAPTIS$142
- INTEGRA DERMAL REGENERATION TEMPLATE$139
- PRIMATRIX$139
How this compares
$404,249 in reported general payments places this provider in the 95th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 22 | $556 |
| Pregabalin | 18 | $409 |
| Ketoconazole | 28 | $242 |
| Meloxicam | 43 | $91 |
| Ibuprofen | 14 | $85 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Houston
- Kevin VarnerHouston$1.1M
- Sherman NaglerHouston$602K
- Orlando RiveraHouston$384K
- Brian LepowHouston$309K
- Yueh LeeHouston$95K
- William GranberryHouston$84K
- Nathaniel AlabiHouston$71K
- Jorge MatukHouston$45K
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.